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Abstract
Objective: In southeast Yemen, visceral leishmaniasis (VL) is endemic in Lahj and Abyan and also in Hagga and Sadah, 
the areas lacking adequate diagnostic facilities. This study describes the clinical and hematological features in 64 cases 
of childhood VL.
Material and Methods: All children below 12 years of age who were managed as inpatient cases from 1 January to 31 
December 2005 were included in this study. The diagnosis of VL was established by demonstration of leishmania parasites 
in bone marrow aspiration. Demographic information, physical signs at presentation and results of complete blood count 
were recorded and bone marrow aspirations were done for LD bodies. 
Results: Mean age of the patients was 30 months, and there were 33 females and 31 males. Fever was seen in 100% 
of children with duration before diagnosis of 56 days. Splenomegaly was present in all cases and hepatomegaly in 84.4%, 
with mean enlargement of spleen and liver of 9.3 and 3.5 cm, respectively. Mean hemoglobin level, white blood cell and 
platelet counts were 6.6 g/dl, 3.58x109 /L and 71.7x109 /L, respectively. Absolute neutrophil count was <0.78x109 /L and 
mean reticulocyte count was 1.7%.
Conclusion: Fever, hepatosplenomegaly and pancytopenia were the most common clinical and hematological manifesta-
tions in Yemeni children with VL. (Turk J Hematol 2009; 26: 25-8)
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Özet
Amaç: Visseral leishmaniasis (VL), yeterli tanı hizmetlerinden yoksun olan Yemen’in güneydoğu bölgesinde yer alan Lahj 
ve Abyan’da ve ayrıca Hagga ve Sadah’da endemiktir.  Bu çalışma 64 çocukluk çağı VL olgusunun klinik ve hematolojik 
özelliklerini tanımlamaktadır. 
Gereç ve Yöntemler: Bu çalışmaya, 1 Ocak’tan 31 Aralık 2005 tarihine kadar hastanede tedavi görmekte olan 12 yaş 
altındaki tüm çocuklar dahil edilmiştir. VL tanısı kemik iliği aspirasyonunda leishmania parazitlerinin gösterilmesi ile 
konmuştur. Demografik bilgi, başvuru sırasındaki fiziksel bulgular, tam kan sayımı sonuçları kaydedilmiş ve LD cisimcikleri 
için kemik iliği aspirasyonları yapılmıştır.In  tro  duc  ti  on
Visceral leishmaniasis (VL) is caused by the parasites of 
Leishmania donovani and is transmitted by the bite of a 
Phlebotomus fly. VL is found in 47 countries of the world, most 
of them being developing countries. It is estimated that approxi-
mately 400.000 individuals are infected annually worldwide [1,2].
Visceral leishmaniasis is a parasitic disease of the reticuloen-
dothelial system characterized by fever, hepatosplenomegaly, 
anemia and leukopenia, and progressive weakness and emacia-
tion, which can result in death if left untreated. Children are at 
greater risk than adults of developing VL in endemic areas [3]. 
Visceral leishmaniasis is endemic in Yemen and most of the 
cases are registered in Lahj, Abyan, Hagga and Sadah gover-
norates [4], the areas lacking adequate diagnostic facilities. 
The diagnosis is mostly missed or delayed for months or years 
and some patients are treated blindly. 
The aim of this study was to document and identify the clinical 
and hematological changes in VL in Yemeni children and to deter-
mine the relation of parasitemia with hematological changes.
Materials and Methods
This study was conducted at Al-Gamhouria Teaching 
Hospital in Aden, Yemen. It included 64 patients diagnosed as 
VL. The diagnosis was confirmed in all patients by identifying 
Leishmania donovani in bone marrow cytology (Figure).
Investigations performed in each patient included complete 
blood count (CBC), differential count and erythrocyte sedimen-
tation rate (ESR). Bone marrow aspirates were taken for 
Leishmania donovani bodies (LD bodies) and evaluation of the 
hematological abnormalities.
Quantitation of LD bodies: The parasite load of LD bodies 
was calculated by counting the number of parasites (LD bodies 
per 100 consecutive oil-immersion fields [OIFs]). LD bodies 
were graded as follows: 1. High grade (>30 LD bodies/100 
OIF); 2. Moderate grade (10-30 LD bodies/100 OIF); and 3. 
Low grade (< 10 LD bodies/100 OIF).
The processing of the obtained data was performed using the 
special statistical package of EpiInfo 2004 to findout the frequen-
cy, percentage, mean values, standard deviation and P values 
 
Results
Sixty-four cases were diagnosed as childhood VL during 
the period from 1 January to 31 December 2005. Thirty-three 
patients were female and 31 were male. Both sexes were 
affected. In infancy, males were affected more than females 
(66.7% and 33.3%, respectively), while after infancy there was 
no significant difference in the percentages of those affected 
according to gender. 
Clinical examination of patients with VL revealed that all had 
fever and splenomegaly. Other common symptoms were 
weight loss and abdominal distension (67.2% for each) and 
fatigue (65.6%). The common signs were pallor (84.4%) and 
hepatomegaly (76.6%). Lymph node enlargement was seen in 
17.2% (Table 1). 
Blood investigation revealed hemoglobin concentration rang-
ing from 2.4 to 10 g/dl (mean: 6.6±1.7 g/dl). The red blood cell 
count ranged from 0.8 to 3.5x1012/L (mean: 2.4±0.6x1012/L. 
Total white blood cell count ranged from leukopenia of 1.1x109/L 
to near normal count of 8.5 x 109/L (mean: 3.5±1.6x109/L). The 
mean absolute neutrophil count was 0.78±0.56x109/L (range: 
0.032 to 2.31x109/L). The platelets also showed a count ranging 
from thrombocytopenia of 5x109/L to normal range of 188x109/L 
(mean: 71.7±41x109/L) (Table 2).
The presence of peripheral pancytopenia was noticed in 45 
patients (70.3%) with VL, while the remaining patients had 
anemia plus either leukopenia or thrombocytopenia. 
The ESR ranged from 22 to 135 mm/hour (mean: 71.9±28.9 
mm/hour). Reticulocyte count ranged from normal value of 
0.2% to 6.5% (mean: 1.7±1.5%). Table 3 shows abnormalities 
of the blood smear in Yemeni children with VL and Table 4 
presents the relation between hematological parameters and 
the level of parasitemia.
Bulgular: Hastaların ortalama yaşı 30 aydı. Otuz üçü kız ve 31’i erkekti. Çocukların %100 ünde tanıdan önce 56 gün süren 
ateş görüldü. Dalak ve karaciğerde sırasıyla 9.3 cm ve 3.5 cm ortalama büyüme ile tüm olgularda splenomegali ve 
%84,4’ünde hepatomegali vardı. Ortalama hemoglobin düzeyi, lökosit ve trombosit sayıları sırasıyla 6,6 g/dl, 358x109/l ve 
71.7x109 /l idi. Mutlak nötrofil sayısı <0.78x109 /l ve ortalama retikülosit sayısı %1.7 idi.
Sonuç: Visseral leishmaniasis’li Yemenli çocuklarda ateş, hepatosplenomegali ve pansitopeni en sık görülen klinik ve 
hematolojik belirtilerdi.  (Turk J Hematol 2009; 26: 25-8)
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Table 1. Clinical features in pediatric patients with visceral 
leishmaniasis
Clinical features  Cases (n=64)
   No  %
Symptoms:
 Fever  64  100.0
 Weight  loss  43  67.2
 Abdominal  distension  43  67.2
 Cough  29  45.3
 Anorexia  24  37.5
 Vomiting  23  35.9
 Diarrhea  17  26.6
 Bleeding  5  7.9
Signs:
 Splenomegaly  64  100.0
 Pallor  54  84.4
 Hepatomegaly  49  76.6
  Lymph node enlargement  13  20.3
 Skin  rash  5  7.8
 Pitting  edema  2  3.1Discussion
Visceral leishmaniasis (VL) is a major health problem in 
Yemen and affects predominantly infants and young children. 
According to the World Health Organization (WHO), leishma-
niasis affects around two million people annually, 500.000 
cases of which are of the visceral form. It is estimated that 350 
million people are exposed to the risk of infection, with a 
global prevalence of 12 million infected individuals [4]. 
The characteristics of the current study are similar to previ-
ous studies, with VL predominating among five year olds, 
mainly the toddler (1-3 years) age group [5,6]. The mean age 
of children was 2.6 years. Children of both sexes were approx-
imately equally affected, and a significant variation was not 
expected due to the similar rate of exposure in children regard-
less of sex difference [7]. 
The major clinical symptoms in this study were fever in 64 
patients (100%), similar to results reported in other studies 
[8,9]. Abdominal distension was seen in 43 patients (67.2%), 
with similar reports in Bangladesh (67%) [10] and Saudi Arabia 
(76.8%) [8]. The mean duration of fever at presentation was 8 
weeks (range: 2 to 21 weeks). Campose et al. [11] had report-
ed a period of 1-6 months in 78% of patients and another 
study in Malta reported the mean duration as 4-8 weeks [12]. 
Splenomegaly was present in 100% of patients in this study 
and other similar studies [13,14]. The mean size of the spleen 
was 9.3 cm. Al-Orainey et al. [8] in a Saudi study found 85.9% 
of patients had spleen size of more than 5 cm. Other studies 
found the mean size of the spleen as 6.8 cm among Pakistani 
children and 11 cm in Somalia children [15]. The increased 
spleen size in Somalia and Yemeni children was probably due 
to the long duration of symptoms before presentation to the 
hospital [16]. VL with massive splenomegaly could be associ-
ated with hypersplenism and consequent anemia, leukopenia 
and thrombocytopenia [17].
Pancytopenia was the most frequent hematological abnor-
mality in our patients (70.3%). Sud et al. [18] and Mathur et al. 
[19] found pancytopenia in 57.8% and 88%, respectively. The 
reason for the higher frequency of pancytopenia is probably the 
long duration of symptoms and splenomegaly before presenta-
tion to the hospital and increased peripheral destruction rather 
than bone marrow failure of production as suggested by the 
bone marrow hyperplasia [20]. Anemia of varying degrees was 
present in all cases with a multifactorial etiology, of which nutri-
tional factors have an important bearing. This was obvious 
from peripheral smear findings of anisopoikilocytosis, macrocy-
tosis, hypochromasia and polychromasia [19].
Leukopenia is found with great frequency among VL 
patients. In this study, leukopenia occurred in 67% of the cases 
and neutropenia in 78.1%, which may indicate that a relative 
lymphocytosis or monocytosis accounted for what appeared 
to be total leukocyte count within the normal range [8]. 
Increased neutropenia in VL children is strongly associated 
with massive splenomegaly [20]. Thrombocytopenia is a com-
mon finding in VL patients, and is exhibited in 40% to 65% of 
patients [5]. Helmi et al. [21] in Iraq and Rahim et al. [22] in 
Pakistan found thrombocytopenia in 80-90% of the patients, 
similar to our results. Although our results reported 90% throm-
bocytopenia, and the mean platelet count was 72x109 /L, the 
thrombopoiesis was normal in the majority of the bone marrow 
studied. It is postulated that the thrombocytopenia observed in 
the peripheral blood may have been due to hypersplenism, and 
partly due to poor platelet formation [23].
The relation between parasite load in the bone marrow and 
the degree of anemia, leukopenia, and thrombocytopenia has 
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Table 2. Clinical and hematological profile in pediatric patients 
with visceral leishmaniasis
Clinical and hematological profile  Cases (n=64)
 Mean  SD  Range
Age (years)  2.6  2.01  2/12-12
Duration of symptoms (weeks)  8.0  5.0  2-21
Spleen (cm)  9.3  2.6  2-16
Hemoglobin (g/dl)  6.6  1.7  2.4-10.0
Red blood cells (x1012/L) 2.4  0.6  0.8-3.5
White blood cells (x 109/L) 3.5  1.6  1.1-8.5
Neutrophils  (x 109/L) 0.78  0.56  0.03-2.31
Platelets (x 109/L) 71.7  41.0  5-188
ESR (mm/hr)  71.9  28.9  22-135
Reticulocyte (%)  1.7  1.5  0.2-6.5
Table 3. Abnormalities of blood smear in Yemeni children with VL
Blood smear findings  Cases (n=64)
   No  %
Red Blood Cells
Hypochromic microcytic  32  50
Macrocytic normochromic  13  20.3
Dimorphic 14  21.9
Anisocytosis 24  37.5
Poikilocytosis 25  39.1
Knizocyte 27  42.2
Schistocytes 16  25.0
Target cells 9  14.1
Rouleaux formation  58  90.6
White Blood Cells/Platelets
 Decreased neutrophils  50  78.1
 Increased lymphocytes  6  9.4
Decreased lymphocytes  5  7.8
Increased monocytes  2  3.1
Decreased platelets  60  93.8
Table 4. Blood parameters in relation to the level of parasitemia 
in children with visceral leishmaniasis
Parasitemia Hemoglobin  WBC  Platelets 
 (g/dl)  (X109/L) (X  109/L)
 Mean±SD  Mean±SD  Mean±SD
Low 7.0±1.6  3461.1±1193.7  85555.5±39207.1
Moderate 6.0±1.8  3655.0±1886.6  74400±50956.5
High 6.9±1.6  3465.4±1597.2  59961.5±30588.2
P value  P=0.10  = 0.90  = 0.10
WBC: White blood cells, SD: standard deviationvaried in different studies. Sud et al. [18] found a direct correla-
tion of parasitemia and the degree of anemia; at the same time, 
there was no correlation of the parasite index with leukopenia 
or thrombocytopenia. On the other hand, Marwah [24] and 
other workers found that the hemoglobin level and platelet 
count were related to parasite load. In our findings, there was 
an increase in the parasite load in children with severe anemia, 
leukopenia and thrombocytopenia, but less significant than 
that reported by Sud et al. [18] and Marwah et al. [24]. 
In conclusion, in our study, the most common presentation 
was fever followed by abdominal distension, and the most 
common sign was splenomegaly followed by pallor and 
hepatomegaly. Pancytopenia was the most frequent hemato-
logical abnormality in VL patients. Leukopenia is due mainly to 
a reduction in neutrophils. 
This study shows that VL in children, particularly in areas 
endemic for the disease, is a recognized problem. It is essential 
that the Ministry of Public Health be more aware of the condi-
tion in order to improve environmental sanitation and personal 
protective measures and to establish diagnostic laboratories 
for early and correct diagnosis and treatment. 
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Figure 1. Bone marrow cytology with high-grade parasitemia